Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cigna Corp (CI) vs Palantir Technologies Inc (PLTR) Price & Performance

Cigna CorpTrade
Palantir Technologies IncTrade

Price performance (Past 24H)

Key statistics

Cigna Corp vs Palantir Technologies Inc — how do they compare? Cigna Corp trades at $299.11 (market cap $80.25B), while Palantir Technologies Inc trades at $134.35 (market cap $320.57B). The key difference: Palantir Technologies Inc is far larger — about 4× Cigna Corp's market cap, and Cigna Corp pays a 2.06% dividend while Palantir Technologies Inc pays none. Which is the better fit depends on your goals.

CIPLTR
Market Cap
$80.25B$320.57B
Sector
HealthTechnology
52-Week High
$311.00$207.18
52-Week Low
$244.41$107.27
Enterprise Value
$103.35B$312.75B
Dividend Yield
2.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cigna Corp

Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.

The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.

Palantir Technologies Inc

PLTR trades at $130.05, up 2.57% today, with technical indicators showing neutral signals amid bearish moving averages. The company demonstrates exceptional fundamental strength with 2025 revenue of $4.48B and net income of $1.63B, representing a 36.3% profit margin. Recent quarterly earnings have consistently beaten expectations, with Q1 2026 EPS of $0.33 surpassing the $0.28 estimate. Analyst consensus remains positive with a $185.75 price target, though valuation metrics remain elevated at P/E of 146.11 and P/S of 63.97.

PLTR presents a growth opportunity with strong AI positioning and expanding profitability, but faces significant valuation risk and competitive pressures. The stock's premium multiples require sustained high growth to justify current levels, while upcoming Q2 2026 earnings on August 3 will be critical for validating the growth trajectory. Institutional sentiment remains divided with 46% buy ratings versus 42% hold recommendations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cigna Corp

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.

Read more on CI

About Palantir Technologies Inc

Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.

Read more on PLTR